A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection.
<h4>Background</h4>Control of onchocerciasis as a public health problem in Africa relies on annual mass ivermectin distribution. New tools are needed to achieve elimination of infection. This study determined in a small number of Onchocerca volvulus infected individuals whether moxidecti...
Saved in:
| Main Authors: | Kwablah Awadzi, Nicholas O Opoku, Simon K Attah, Janis Lazdins-Helds, Annette C Kuesel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-06-01
|
| Series: | PLoS Neglected Tropical Diseases |
| Online Access: | https://doi.org/10.1371/journal.pntd.0002953 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics of oral moxidectin in individuals with Onchocerca volvulus infection.
by: Beesan Tan, et al.
Published: (2022-03-01) -
Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity.
by: Stephen R Doyle, et al.
Published: (2017-07-01) -
Elimination of Onchocerca volvulus Transmission in the Huehuetenango Focus of Guatemala
by: Nancy Cruz-Ortiz, et al.
Published: (2012-01-01) -
Active infection with Onchocerca volvulus and the linkage to epilepsy/nodding syndrome.
by: Kathrin Arndts, et al.
Published: (2024-05-01) -
Spatial proteomics of Onchocerca volvulus with pleomorphic neoplasms shows local and systemic dysregulation of protein expression.
by: Lucia S Di Maggio, et al.
Published: (2025-03-01)